ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

XAR Xaar Plc

114.50
-5.50 (-4.58%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Xaar Plc LSE:XAR London Ordinary Share GB0001570810 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -5.50 -4.58% 114.50 116.50 121.50 120.00 118.00 120.00 87,820 16:35:12
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Commercial Printing, Nec 72.78M 1.63M 0.0208 56.73 92.73M
Xaar Plc is listed in the Commercial Printing sector of the London Stock Exchange with ticker XAR. The last closing price for Xaar was 120p. Over the last year, Xaar shares have traded in a share price range of 90.60p to 190.00p.

Xaar currently has 78,585,642 shares in issue. The market capitalisation of Xaar is £92.73 million. Xaar has a price to earnings ratio (PE ratio) of 56.73.

Xaar Share Discussion Threads

Showing 6026 to 6050 of 6125 messages
Chat Pages: 245  244  243  242  241  240  239  238  237  236  235  234  Older
DateSubjectAuthorDiscuss
12/1/2023
07:57
Bit mixed. Cash loss of 4m. You would expect that when launching a product and building an inventory. Hopefully covid will pass reasonably quickly through china. Seems they met current sales forecasts, will see what the brokers say
dr biotech
12/1/2023
07:38
The emphasis is on the long term which usually forecasts a profit warning in the short term.

Challenging macro conditions expected to continue into 2023

Sales volumes in the Printhead business continue to be affected by the uncertainty in China, which is expected to continue in the short term as Covid cases increase. At this stage it remains unclear when normal levels of business will return.
notwithstanding the challenging external environment, the business is in good shape to continue to make further progress over the long term.

mr macgregor
12/1/2023
07:26
"I am hugely proud of the team in delivering a strong performance and making further progress with our strategy. We expect to deliver strong profitable revenue growth and the important milestone of achieving full year profitability representing great progress against our plan and remain well positioned for the business to achieve its exciting potential."
ayl30
12/1/2023
07:10
All seems ok from today's latest update, mgt seem confident and factory rebuild on plan
ayl30
18/11/2022
08:08
From Progressive research today..


Xaar announced on Wednesday the release of its Aquinox printhead for use with water-based inks. This is a major step forward for Xaar and for aqueous inkjet printing. Aquinox is the latest printhead to work on Xaar’s ImagineX platform and helps open up new markets, most notable packaging and textiles. It also enables Xaar to take advantage of increasing demands in other markets, notably ceramics…

dr biotech
17/11/2022
19:06
I bought a few! No stock around...
edwardt
01/11/2022
16:12
Nice rise today. Any ideas why?
dhurms
14/10/2022
11:16
Odyssean past 10% yesterday.
brucie5
12/10/2022
16:46
30% drop in a month. I’ve a few like this unfortunately, market has capitulated with some.
dr biotech
21/9/2022
15:52
A leader in the development of inkjet technology has been successfully turned around and is now delivering strong organic sales growth, and profits.
September 20, 2022
By Simon Thompson

zho
20/9/2022
09:20
No comment? These look pretty good to me.

Summary of results for the six months ended 30 June 2022:


2022 2021(1) Change
Continuing Operations
---------- ---------- ------
Revenue GBP36.6m GBP26.3m +39%
---------- ---------- ------
Gross profit GBP14.5m GBP8.3m +75%
---------- ---------- ------
Gross margin % 40% 31% +9ppts
---------- ---------- ------
Gross R&D investment GBP3.3m GBP2.6m +27%
---------- ---------- ------
Adjusted EBITDA(2) GBP3.0m GBP0.3m
---------- ---------- ------
Adjusted profit/(loss) GBP1.4m (GBP1.6m)
before tax(2)
---------- ---------- ------
Loss before tax (GBP0.3m) (GBP1.4m)
---------- ---------- ------
Profit/(loss) for the GBP0.7m (GBP1.3m)
period after tax
---------- ---------- ------
Basic earnings per share 0.9p (1.6p)
---------- ---------- ------

Total Operations
---------- ---------- ------
Loss before tax (GBP0.6m) (GBP4.2m) +85%
---------- ---------- ------
Profit/(loss) for the
period after tax GBP0.4m (GBP4.3m) +108%
---------- ---------- ------
Basic earnings per share 0.5p (3.8p) +112%
---------- ---------- ------

Net cash at the period
end(3) GBP12.7m GBP17.1m -26%
---------- ---------- ------

brucie5
02/9/2022
09:49
30 August 2022

Xaar plc

Notice of 2022 Half Year Results

Xaar plc, the leading inkjet printing technology group, will announce its half year results for the six months ended 30 June 2022 at 7.00am (BST) on Tuesday 20 September 2022.

bigbigdave
28/7/2022
09:20
Nice 'bowl' forming -->270p IMO.
gymratt
24/7/2022
13:23
Well, yes and no. A stonkingly high PE can also be evidence of an overvalued share price.
It really depends on growth in those earnings, hence Slater's interest in PEG ratio. But the case for XAR, I believe, having listened to CR, is its reinvention on basis of its IP larder, and potential demand for its new aquieous ink product, with enhanced ESG.

brucie5
20/7/2022
12:13
Yes agree!!!
meijiman
20/7/2022
11:52
Just read the same book myself. Excellent!
johndoe23
20/7/2022
11:18
Just been reading Mark Minervini book on investing. Compelling case for looking at high P/E growth stocks as the best companies grow into the rating with earnings beats.
meijiman
20/7/2022
10:54
Got in below 200p thanks !
superadams
20/7/2022
08:57
The products lined up for release in H2 2022 & 2023 should shrink that P/E dramatically.

There has been a seller of late who appears to have dried up.
SP should go back to the previous high. My LTBH target is 500p.
A classic recovery situation...

napoleon 14th
15/7/2022
12:02
Attracted by this co but are shares really on a forward PER of nearly 30 ??
superadams
15/7/2022
09:44
and more commentary from Progressive today after the update yesterday (Paid for "research" of course but a good way for the co to communicate with investors outside scheduled updates)

Xaar’s H1 trading update for 6M ended 30th June 2022, issued yesterday, confirms that the group is trading well, with increased revenues, improving margins, costs under control and new products launching to schedule. Xaar is clearly back onto a robust growth trajectory. We are maintaining our forecasts and look forward to the interims in September as an opportunity find out more about how the momentum is building.
▪ Revenues and profits growth in line with expectations - The statement confirms that after a strong H1, performance for the full year at PBT level is seen as being in line with expectations. Revenues for H1 are expected to be approx. £37m – 41% up YoY and 14% up on an organic basis before the FFEI and Megnajet. The strong revenue growth has been accompanied by increased gross margins and effective actions on costs.
▪ Investment continues – Net Cash as at 30th June was £12.6m, down from the year end figure of £15.3m. This is consistent with our forecasts, given the acquisition of Megnajet, the ongoing capital investments and the requirement to increase working capital to protect Xaar from supply chain issues and to ensure that customers’ requirements are met.
▪ Trading encouraging on all fronts - The core printhead division has traded well, with European and US growth offsetting the Covid related slowdown in China. The product print business, eps, has seen both revenue and margin growth.
▪ Product development going to plan - The statement confirms that not only has trading performance been good, but so has progress with new product development. A new printbar product was launched in H1 by FFEI, but most importantly the company remains on track to launch the much-anticipated aqueous printhead product in Q4 2022.
▪Price increases, not just cost cutting - The statement refers to management actions to mitigate the impact of cost increases – not least of which is the fact that Xaar has successfully put through sales price increases. This is a timely and reassuring reminder that it has products, skills and technologies that customers value and are willing to pay up for.
Xaar offers investors a clear, understandable tech growth story with a near $1bn addressable market opportunity and a management team that is demonstrating its ability to execute. We continue to question whether the value of this combination is fully reflected in the share price.

se81
14/7/2022
07:33
Good results this am, nice solid little company
ayl30
22/6/2022
07:43
Progressive out with a new (free) note this morning....some interesting stuff in there (re the business, products, future growth etc)- headline summary below

With a clear roadmap of new digital inkjet products and an ambitious
management team focused on gaining (or retaining) significant market
shares across the segments that make up its $1bn addressable market, Xaar
is positioned to grow strongly. Management has already demonstrated its
abilities in turning the business around, and we believe it is far from clear
that the share price fully reflects the opportunities ahead.

▪ $1bn market awaits. The market for industrial digital inkjet printheads is
estimated by management to be approaching $1bn per annum. Xaar’s
product roadmap suggests that it will be able to address the vast majority
of this within a few years. If the management team delivers on the
product roadmap, Xaar will be well-positioned to take a strong share of
these markets.

▪ Clear signs of progress. Management has a strategy in place to drive
revenue back up by launching new products and adopting a revised
approach to customers and the channel. Improving revenues and a
growing number of customer products both in development and in the
market show that management is already delivering on this strategy.

▪ Profit and cashflow upside. The high gross margin and relatively fixed cost
base mean that as product and revenue traction build, the impact on the
bottom line will be geared upwards. On top of this, the significant
historical capital investment means that material increases in output can
be achieved for limited capital outlay: a possible positive profit and
cashflow double whammy.

▪ ESG potential. Management believes that Xaar can reduce overall ink and
energy consumption, most notably with the launch of its aqueous ink
capable printheads, which use significantly less water than standard
printheads and save on the heat energy used to dry the inks.
Starting from £40m revenue in printheads in FY21, a near $1bn addressable
market opportunity and a management team that has shown itself able to
execute, even though the shares are on premium multiples, the market
valuation appears that it may not fully reflect the scale of Xaar’s potential
revenue and profit growth. Xaar offers investors a clear, understandable
technology growth story, building on an established set of technologies
providing solutions across a range of demanding printing applications.

se81
25/5/2022
23:34
Beautiful triangle forming on the graph here. Will need to break out soon as we are just about to reach the tip of the triangle.
simmsc
11/5/2022
15:23
Nice tick up today, about time
ayl30
Chat Pages: 245  244  243  242  241  240  239  238  237  236  235  234  Older

Your Recent History

Delayed Upgrade Clock